Last update Feb. 19, 2019
Likely Compatibility
We do not have alternatives for ヒト下垂体性性腺刺激ホルモン.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
ヒト下垂体性性腺刺激ホルモン is Human Menopausal Gonadotrophins (HMG) in Japanese.
Is written in other languages:ヒト下垂体性性腺刺激ホルモン is also known as
ヒト下垂体性性腺刺激ホルモン belongs to this group or family:
Main tradenames from several countries containing ヒト下垂体性性腺刺激ホルモン in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 0 | % |
Molecular weight | 23.390 | daltons |
VD | 1.08 | l/Kg |
Tmax | 8 - 27 | hours |
T½ | 13 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by La Liga de la Leche, España of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Human Menopausal Gonadotrophin (HMG) is a natural hormone present in the urine of menopausal women which has the activity of follicle stimulating hormone (FSH) and luteinizing hormone (LH).
Menotropin is a purified extract of human postmenopausal gonadotrophin containing FSH and LH in a 1: 1 ratio.
Administration by subcutaneous or intramuscular injection.
Indicated to stimulate ovulation in assisted reproduction techniques.
Since the last update we have not found published data on its excretion in breastmilk.
Its high molecular weight makes it very unlikely it will transfer into milk in significant quantities.
Due to its protein nature it is inactivated in the gastrointestinal tract, not being absorbed, so its oral bioavailability is practically nil, except in premature babies and the immediate neonatal period when there may be greater intestinal permeability.
No adverse effects have been recorded in infants.
In infertility treatments, the possible theoretical anovulatory effect of frequent on demand breastfeeding must be taken into account.
See below the information of these related products: